Objective: The objectives ofthis study were to ascertain the acceptance rate ofhuman immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic and clinical characteristics of seropositive women diagnosed in the prenatal setting.
ciency virus (HIV)/acquired immunodeficiency syndrome (AIDS) epidemic has increasingly affected women of childbearing age from racial or ethnic minorities living in urban communities. [1] [2] [3] HIV/AIDS is a leading cause of mortality for these women. A delay in diagnosis and treatment frequently results in increased morbidity from opportunistic infections such as PneumocTstis carinii pneumonia (PCP).S '6 The number of women with AIDS as well as the HIV seroprevalence among parturients in New Jersey is higher than the national average. 7'8 In general, more than 80% of the women in the United States seek the health-care system for reproductive decisions including evaluation for sexually transmitted diseases (STDs), family planning, and pregnancy. For example, in 1986 , approximately 60% of black and hispanic women and 75-80% of white women initiated their prenatal care during the first trimester of pregnancy. Therefore, the availability of HIV-1 counseling and testing programs in these settings could identify and educate women at risk.
In addition, these programs could provide the uninfected woman with knowledge of the modes of HIV Ninety-four percent of the newly identified HIV positive pregnant women belonged to racial or ethnic minority groups. This distribution is representative of the population seen in the prenatal clinic during the study period. The mean age of the seropositive women was 30 6 years, while 10 women were 35 years or older (Fig. 2) (Fig. 3) . z3 The AIDS-defining illnesses seen among the women in this cohort were PCP, AIDS dementia, wasting syndrome, and oroesophageal candidiasis. Overall, 6 patients in this cohort received HIV-related medications during the antepartum period for maternal indications. The drugs used included antiretrovirals (N 3), PCP prophylaxis (N 5), and antituberculosis medications (N 1).
Seventy-three percent (24/33) of the women relied on public-assistance programs for their health PRENATAL HIV-1 COUNSELING AND TESTING PROGRAM BARDEGUEZ ET AL. Most seropositive women in this study were asymptomatic. In contrast to a report by Hutchinson et al., zz the majority (73%) of the pregnant women were negative for syphilis and were not IVDU. These cases would have generally been missed using a risk-assessment approach alone. Of the clinically asymptomatic women, 47% (15/32) had CD4 lymphocyte Counts that met the criteria for the initiation of antiretroviral treatment at the time of diagnosis, lz Furthermore, 22% (7/32) of the women met the criteria for the initiation of PCP prophylaxis. 13 The immunologic compromise of these pregnant women was confirmed by the increase in the number of AIDS cases in the cohort when the 1993 adult/adolescent CDC definition was used ( Figure  3 ). This expanded definition classifies individuals with CD4 lymphocyte counts of <200 cells/mm in the AIDS category (A3) surveillance, z The increased survival observed among subjects on antiretroviral therapy and PCP prophylaxis and the availability of such drugs through a state-supported 
